Source: DGNews  |  Posted 9 years ago

New Indication to Launch in January 2003

PALO ALTO, CA -- December 23, 2002 -- Connetics Corporation (Nasdaq: CNCT), a specialty pharmaceutical company that develops and commercializes dermatology products, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental New Drug Application (sNDA) to expand label claims for Olux